IHE · iShares U.S. Pharmaceuticals ETF

Equity fundTracks an index0.37% fee$1.6bnSince Jan 4, 2010Fund page at the issuer ↗SEC filings ↗

IHE tracks an index and returned +34.4% over the past year.

+34.4%
Total return, 1 year
0.37%
Expense ratio
57
Holdings
−8.5%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026−2.0%+3.6%−5.6 pts−7.3 pts
6M Apr 2 – Oct 2, 2026+14.0%+17.9%−3.9 pts−14.4 pts
1Y Oct 2, 2025 – Oct 2, 2026+34.4%+16.2%+18.1 pts+10.1 pts
3Y Oct 3, 2023 – Oct 2, 2026+78.8%+89.3%−10.5 pts−36.0 pts
Since listing Jan 4, 2010 – Oct 2, 2026+549.7%+813.0%−263.2 pts−1212.2 pts

IHE over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

IHE top ten by weight, 79.0% of its 57 equity positions, from the holdings published by its issuer for Oct 1, 2026. An index fund holds what the index holds, so this is the index. Source: the issuer’s own daily file.

ELI LILLY LLY 23.71%
PFIZER PFE 4.69%
VIATRIS VTRS 4.55%
MERCK & CO INC MRK 4.52%
BRISTOL MYERS SQUIBB BMY 4.42%
ROYALTY PHARMA PLC CLASS A RPRX 4.41%
ZOETIS INC CLASS A ZTS 4.37%

In plain words

IHE tracks an index. Over the year to Oct 2, 2026 it returned +34.4% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.37% a year. By its holdings published by its issuer for Oct 1, 2026, 66% of the fund by weight is stocks the S&P 500 also holds, across 57 positions, with the top ten at 79.0%. It sat 8.5% below its high of Aug 19, 2026 on Oct 2, 2026.
What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Jul 27, 2026)0.37%
Price$98.65
Listed sinceJan 4, 2010
Net assets (the issuer’s own daily fund list, as of Oct 2, 2026)$1.6bn
Below its high (ETFIQ)−8.5%
Holdings57
Top ten weight79.0%
Holdings published for (the issuer’s daily file)Oct 1, 2026
Already in the S&P 500, by weight (ETFIQ)65.6%
Active share vs the S&P 500 (ETFIQ)96.6%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about IHE

How has IHE performed?
Over the year to Oct 2, 2026, IHE returned +34.4% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is +78.8%.
What does IHE cost?
The prospectus expense ratio is 0.37% a year.
What does IHE hold?
57 positions as published by its issuer for Oct 1, 2026, with the top ten at 79.0% of the fund. 66% of its weight is in stocks the S&P 500 also holds.
How far is IHE below its high?
8.5% below its high of Aug 19, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, IHE and S&P 500Tiingo end-of-day · Oct 2, 2026
Net assets, $1.6bnThe issuer’s own daily fund list · Oct 2, 2026

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

Cite this page

ETFIQ, IHE, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/ihe

Free to use with attribution; the underlying files are at Open data.